2021: Volume 4, Issue 1
Commentary P.1-2
Assessment of Type I Interferon Signaling in Inflammatory Diseases
Author(s): Yan Xiong
Editorial P.1-2
Distinctive Features of Kawasaki Disease during SARS-CoV-2 Infection
Author(s): Ronald James
Perspective P.1-2
Typical Immune Responses in Antibody Defects: SARS-CoV-2 Vaccine
Author(s): Jean Laurent Casanova
Editorial P.1-2
Plasma Fatty Acids Associate with Gut Microbial Composition in Common Variable Immunodeficiency
Author(s): Xiang Kong